Advanced search
Publication Cover
HIV Clinical Trials Volume 2, 2001 - Issue 5
Submit an article Journal homepage
33
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Response to Liposomal Doxorubicin and Clinical Outcome of HIV-1–Infected Patients with Kaposi’s Sarcoma Receiving Highly Active Antiretroviral Therapy

M. NúñezHospital Carlos III, Madrid, Spain.Correspondence[email protected].
,
P. SaballsHospital del MarBarcelona
,
M.E. ValenciaHospital Virgen de laVictoria, Málaga
,
J. SantosHospital Príncipes de España, Barcelona
,
E. FerrerHospital de la Princesa, Madrid, Spain
,
I. SantosHospital General Universitario, Valencia, Spain
,
A. BerrocalHospital Clínico, Valencia, Spain
,
M.J. GalindoHospital Carlos III, Madrid, Spain.
,
D. PodzamczerHospital del MarBarcelona
,
J. González-LahozHospital Virgen de laVictoria, Málaga
& the Caelyx/KS Spanish Study Group show all
Pages 429-437 | Published online: 14 Jan 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Alessia Dalla Pria, Katy Hayward & Mark Bower. (2013) Do we still need chemotherapy for AIDS-associated Kaposi’s sarcoma?. Expert Review of Anticancer Therapy 13:2, pages 203-209.
Read now
Francesca Cainelli & Alfredo Vallone. (2009) Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma. Biologics: Targets and Therapy 3, pages 385-390.
Read now
Ashish Udhrain, Keith M Skubitz & Donald W Northfelt. (2007) Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma. International Journal of Nanomedicine 2:3, pages 345-352.
Read now
Alexander Kreuter, Heinrich Rasokat, Mariam Klouche, Stefan Esser, Armin Bader, Thilo Gambichler, Peter Altmeyer & Norbert H. Brockmeyer. (2005) Liposomal Pegylated Doxorubicin versus Low-Dose Recombinant Interferon Alfa-2a in the Treatment of Advanced Classic Kaposi's Sarcoma; Retrospective Analysis of Three German Centers. Cancer Investigation 23:8, pages 653-659.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.